Sign in
Enrolling by invitationNo phase

Follows people receiving a knee replacement device for knee arthritis or fracture

Collects information on a knee replacement device used in adults with knee osteoarthritis.

Key facts

Who runs it
LinkBio Corp.
Where
Birmingham and Libertyville, United StatesSee the 2 sites
Trial code
Registry title
LinkSymphoKnee (LSK) Total Knee Replacement System Study - Ultra-congruent (UC)
Status
Enrolling by invitation
People taking part
600 people, planned
Started
21 Mar 2025
Expected to end
Dec 2031
Type of study
Observational
Treatments tested
  • total knee arthroplasty device
Record updated
3 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults having a first total knee replacement with the LinkSymphoKnee cemented system, as part of their surgeon's usual care.

Age
18 to 79 years old, and fully grown (skeletally mature).
Sex
All sexes can join.
Disease stage
People having a primary (first) total knee replacement on one or both knees. The conditions listed are knee osteoarthritis, fracture and rheumatoid arthritis.
Earlier treatment
People with a poorly working total knee replacement on the other knee, or a revision on the other knee, cannot join.

Main reasons for not taking part

  • 80 years of age or older
  • Pregnant at the time of surgery
  • History of joint infection (joint sepsis)
  • Bone defect that needs grafting
  • Bone disease or a condition affecting bone density that the surgeon thinks is severe enough to compromise device fixation

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • 18 years or older, and skeletally mature; and
  • Undergoing a primary TKA for one or both knees using the cemented LinkSymphoKnee knee system as part of the surgeon's standard of care
  • Able to read and understand English (because patient-reported outcome questionnaires are not validated for all potential other languages)

Who cannot take part

  • Women who are pregnant at the time of surgery,
  • Previous history of bone disease (e.g., severe osteoporosis or osteomalacia) which in the surgeon's opinion is severe enough to compromise device fixation,
  • History of joint sepsis,
  • Systemic conditions affecting bone density (e.g., inflammatory arthritis or renal disease) which in the surgeon's opinion are severe enough to compromise device fixation,
  • 80 years of age or older,
  • Bone defect that requires grafting,
  • A poorly functioning contralateral total knee replacement or a contralateral revision regardless of function

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 79 years old?

Where in United States

  • OrthoAlabama Spine & SportsBirmingham, United StatesEnrolling by invitation
  • Illinois Bone and Joint InstituteLibertyville, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

To collect information about implant performance and patient clinical outcomes in patients undergoing primary total knee arthroplasty with the LinkSymphoKnee total knee replacement system with ultra-congruent tibial bearing surface.

Treatments tested

  • total knee arthroplasty device

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
LinkSymphoKnee (LSK) Total Knee Replacement System Study - Ultra-congruent (UC)
Plain-language title
Follows people receiving a knee replacement device for knee arthritis or fractureGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06670651, who can take part
Record updated
3 September 2026